These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32955983)

  • 1. Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Goldfarb DA
    J Urol; 2020 Dec; 204(6):1369. PubMed ID: 32955983
    [No Abstract]   [Full Text] [Related]  

  • 2. The Use of Hepatitis C Virus-Positive Organs in Hepatitis C Virus-Negative Recipients.
    Kuntzen C; Bagha Z
    Clin Liver Dis; 2022 May; 26(2):291-312. PubMed ID: 35487612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.
    Daloul R; Pesavento TE; Goldberg DS; Reese PP
    Kidney Int; 2021 Dec; 100(6):1190-1198. PubMed ID: 34237327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era.
    Schaubel DE; Tran AH; Abt PL; Potluri VS; Goldberg DS; Reese PP
    JAMA; 2022 Sep; 328(11):1102-1104. PubMed ID: 35994263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts.
    El Helou G; Jay C; Nunez M
    Transplant Rev (Orlando); 2022 Jan; 36(1):100677. PubMed ID: 35063799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications.
    Sutcliffe S; Ji M; Chang SH; Stewart D; Axelrod DA; Lentine KL; Wellen J; Alrata L; Gupta G; Alhamad T
    Am J Transplant; 2023 May; 23(5):629-635. PubMed ID: 37130619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
    Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
    Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant of Kidneys From Hepatitis C Virus-Positive Donors To Hepatitis C Virus-Negative Recipients: A Retrospective Study and Systematic Review.
    Shadekejiang H; Zhu J; Wu X
    Exp Clin Transplant; 2022 Dec; 20(12):1076-1084. PubMed ID: 36718006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Tissue Transmission of Hepatitis C Virus From Viremic Donor to Seronegative Kidney Transplant Recipients: A Case Series.
    Franco A; Gosalvez C; Gimeno A; Trigueros M; Balibrea N; Perez Contreras FJ
    Transpl Int; 2023; 36():11110. PubMed ID: 37534060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial.
    Desai NM; Leung SG; Motter JD; Segev DL; Warren D; Durand CM
    Ann Intern Med; 2023 Dec; 176(12):1682-1684. PubMed ID: 38011702
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
    Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Ultra-Short Duration Direct Acting Antiviral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients.
    Goldfarb DA
    J Urol; 2020 Oct; 204(4):868. PubMed ID: 32701370
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Chute DF; Chung RT; Sise ME
    Kidney Int; 2018 Mar; 93(3):560-567. PubMed ID: 29325996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of a Hepatitis C-Positive Patient Who Received Kidney Transplant From a Hepatitis C-Positive Donor: A Case Report.
    Papayannis I; Patel P
    Prog Transplant; 2016 Sep; 26(3):238-40. PubMed ID: 27597771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ Donors with Human Immunodeficiency Virus and Hepatitis C Virus: Expanding the Donor Pool.
    Salas J; Storm K; Durand CM
    Infect Dis Clin North Am; 2023 Sep; 37(3):641-658. PubMed ID: 37258326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral Agents.
    Graham JA; Ajaimy M; Carrero J; Jones T; Torabi J; Alani O; Akalin E; Rocca JP
    Prog Transplant; 2019 Dec; 29(4):371-372. PubMed ID: 31533529
    [No Abstract]   [Full Text] [Related]  

  • 19. Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting antiviral therapy without ribavirin.
    Kapila N; Flocco G; Al Khalloufi K; Zervos XB
    J Viral Hepat; 2019 Mar; 26(3):407-409. PubMed ID: 30449062
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.